The role of IL-17 on RA has been extensively studied [7,12,13]; therefore, this review will focus on the role of IL-17 in the pathogenesis of other systemic rheumatic diseases, mainly SLE, SS and SSc, as well as the potential therapeutic intervention on these diseases. Here, IL17A is linked to systemic sclerosis.